Gunnar Magnus Modee Persson

Gunnar Magnus Modee Persson

Chairman chez INITIATOR PHARMA A/S

Fortune : 62 064 $ au 31/03/2024

64 ans
Health Technology
Finance
Electronic Technology

Profil

Gunnar Magnus Modee Persson is the founder of Aerocrine AB, which was founded in 1994.
He currently holds multiple chairman positions at Cantargia AB, Attgeno AB, Galecto Biotech ApS, Karolinska Institutet Information AB, Initiator Pharma A, Hip Health Innovation Platform AB, Galecto Biotech AB, Eir Ventures Partners AB, Gyros AB, Avalo Therapeutics, Inc., Medical Prognosis Institute, Inc., Albumedix A, Mordin AB, Själbådan AB, Gyros Protein Technologies Holding AB, Perma Ventures AB, ADDI Medical AB, P O Persson.
i Lidingö AB, Duomedix AB, Merigen AB, Sls Ventures AB, Avalo, Inc., and Karolinska Institutet.
He has also held former positions as Chief Executive Officer of Karolinska Institutet Holding AB, Chief Executive Officer & Associate Professor of Caerus Consulting AS, Chairman of Scandinavian Life Science Ventures AB, Acting Chairman of Altimmune UK Ltd., Chairman of Karolinska Institutet Innovations AB, Chairman of Karolinska Institutet University Press AB, Chairman of Galecto, Inc., Chairman of Bioworks AB, Director of Ascendx Spine, Inc., Independent Director of Abliva AB, Director-Supervisory Board of Trigen Holdings AG, Director of Healthcap III Sidefund GP AB, Director of Lumavita AG, Director of KCIF Fund Management AB, Director of Medical Prognosis Institute A, Independent Director of Contera Pharma ApS, Independent Director of Karolinska Development AB, Independent Director of Mendus AB, Director of Bio-Works Technologies AB, Director of Karolinska Institutet Support AB, Director of Karolinska Institutet Housing AB, Director of Karolinska Institutet Science Park, Independent Director of Allarity Therapeutics A, Director of Addi Optioner AB, Partner of HealthCap AB, Principal of Odlander, Fredrikson & Co. AB, Gérant of Sanofi Winthrop, and Managing Partner of The Column Group LLC.
He holds a doctorate degree from Karolinska Institutet.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/12/2022 190 154 ( 0,10% ) 62 064 $ 31/03/2024

Postes actifs de Gunnar Magnus Modee Persson

SociétésPosteDébut
AVALO THERAPEUTICS, INC. Director/Board Member 28/08/2012
CANTARGIA AB Chairman 01/01/2016
INITIATOR PHARMA A/S Chairman 01/01/2016
Chairman -
Chairman 01/01/2018
Director/Board Member 01/10/2015
Medical Prognosis Institute, Inc. Director/Board Member -
Mordin AB Corporate Officer/Principal -
Galecto Biotech AB Chairman -
░░░ ░░░░░░░░ ░░░░░░░░ ░░ ░░░░░░░░ ░░░░░░░░░░
░ ░ ░░░░░░░ ░ ░░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
Tous les postes actifs de Gunnar Magnus Modee Persson

Anciens postes connus de Gunnar Magnus Modee Persson

SociétésPosteFin
░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░ ░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Gunnar Magnus Modee Persson

Formation de Gunnar Magnus Modee Persson

Karolinska Institutet Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Gunnar Magnus Modee Persson

Relations

100 +

Relations au 1er degré

51

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées8
ABLIVA AB

Health Technology

CANTARGIA AB

Health Technology

KAROLINSKA DEVELOPMENT AB

Finance

AVALO THERAPEUTICS, INC.

Health Technology

MENDUS AB

Health Technology

BIO-WORKS TECHNOLOGIES AB

Health Technology

INITIATOR PHARMA A/S

Health Technology

GALECTO, INC.

Health Technology

Entreprise privées42

Electronic Technology

Health Technology

Health Technology

Finance

Finance

Health Technology

Miscellaneous

Commercial Services

Finance

Health Technology

Healthcap III Sidefund GP AB

Finance

Finance

Health Services

KCIF Fund Management AB

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Medical Prognosis Institute, Inc.

Health Technology

Karolinska Institutet Information AB

Mordin AB

Consumer Services

Technology Services

Commercial Services

Finance

Finance

Finance

Electronic Technology

Finance

Health Technology

Technology Services

Addi Optioner AB

Galecto Biotech AB

Bioworks AB

Finance

P O Persson i Lidingö AB

Duomedix AB

Merigen AB

Sls Ventures AB

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Gunnar Magnus Modee Persson